Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications

•Mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles were synthesized.•Nanoparticles combined targeting, imaging and therapeutic ability in a single entity.•Drug loaded nanoparticles exhibited cytotoxicity to cancer cells.•Nanoparticles performed as superior MRI contrast agent...

Full description

Saved in:
Bibliographic Details
Published inJournal of colloid and interface science Vol. 431; no. 431; pp. 31 - 41
Main Authors Sahoo, Banalata, Devi, K. Sanjana P., Dutta, Sujan, Maiti, Tapas K., Pramanik, Panchanan, Dhara, Dibakar
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.10.2014
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles were synthesized.•Nanoparticles combined targeting, imaging and therapeutic ability in a single entity.•Drug loaded nanoparticles exhibited cytotoxicity to cancer cells.•Nanoparticles performed as superior MRI contrast agent for cancer cells. Multifunctional mesoporous silica-coated superparamagnetic manganese ferrite (MnFe2O4) nanoparticles (M-MSN) were synthesized and evaluated for targeted drug delivery and magnetic resonance imaging (MRI) applications. MnFe2O4 nanoparticles were prepared by solvothermal route and were silica-coated by surface silylation using sol–gel reactions. Subsequently, silylation was done using (3-aminopropyl)triethoxysilane in presence of a surfactant (CTAB), followed by selective etching of the surfactant molecules that resulted in amine-functionalized superparamagnetic nanoparticles (NH2-MSN). Further modification of the surface of the NH2-MSN with targeting (folate) or fluorescent (RITC) molecules resulted in M-MSN. The formation of the M-MSN was proved by several characterization techniques viz. XRD, XPS, HRTEM, FESEM, VSM, BET surface area measurement, FTIR, and UV–Vis spectroscopy. The M-MSN were loaded with anticancer drug Doxorubicin and the efficacy of the DOX loaded M-MSN was evaluated through in vitro cytotoxicity, fluorescence microscopy, and apoptosis studies. The in vivo biocompatibility of the M-MSN was demonstrated in a mice-model system. Moreover, the M-MSN also acted as superior MRI contrast agent owing to a high magnetization value as well as superparamagnetic behavior at room temperature. These folate-conjugated nanoparticles (FA-MSN) exhibited stronger T2-weighted MRI contrast towards HeLa cells as compared to the nanoparticles without folate conjugation, justifying their potential importance in MRI based diagnosis of cancer. Such M-MSN with a magnetic core required for MRI imaging, a porous shell for carrying drug molecules, a targeting moeity for cancer cell specificity and a fluorescent molecule for imaging, all integrated into a single system, may potentially serve as an excellent material in biomedical applications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9797
1095-7103
DOI:10.1016/j.jcis.2014.06.003